640 related articles for article (PubMed ID: 1319456)
21. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
22. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG
J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
[TBL] [Abstract][Full Text] [Related]
23. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
24. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
25. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
26. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
[TBL] [Abstract][Full Text] [Related]
27. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
28. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
[TBL] [Abstract][Full Text] [Related]
29. Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.
Khanna R; Jacob CA; Burrows SR; Moss DJ
J Immunol Methods; 1993 Aug; 164(1):41-9. PubMed ID: 7689619
[TBL] [Abstract][Full Text] [Related]
30. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
31. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
[TBL] [Abstract][Full Text] [Related]
32. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
[TBL] [Abstract][Full Text] [Related]
33. Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies.
Kanno H; Nakatsuka S; Iuchi K; Aozasa K
Int J Cancer; 2000 Nov; 88(4):626-32. PubMed ID: 11058881
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
[TBL] [Abstract][Full Text] [Related]
35. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus.
Subklewe M; Chahroudi A; Schmaljohn A; Kurilla MG; Bhardwaj N; Steinman RM
Blood; 1999 Aug; 94(4):1372-81. PubMed ID: 10438725
[TBL] [Abstract][Full Text] [Related]
36. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
[TBL] [Abstract][Full Text] [Related]
37. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM
Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
Misko IS; Schmidt C; Moss DJ; Burrows SR; Sculley TB
J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
